» Articles » PMID: 30603671

Predictive Power of Model for End-Stage Liver Disease and Child-Turcotte-Pugh Score for Mortality in Cirrhotic Patients

Overview
Specialty Gastroenterology
Date 2019 Jan 4
PMID 30603671
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Aim Of The Study: To assess the performance of Child-Turcotte-Pugh (CTP) and Model for End-Stage Liver Disease (MELD) scores' kinetics during hospitalization in predicting in-hospital mortality in patients with liver cirrhosis.

Material And Methods: One hundred and seventy-four cases of hospitalized liver cirrhosis patients were selected. The diagnosis of cirrhosis was made based on clinical, biochemical, ultrasonic, histological, and endoscopic findings and results. CTP and MELD scores at admission and ΔCTP and ΔMELD were calculated. Univariate and multivariate logistic regression and receiver-operating characteristic (ROC) curve analysis were performed. In the models, odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. The area under the ROC curve (AUC) was used to measure the accuracy. For the optimal cutoff point, sensitivity (SE), specificity (SP), positive predictive value (PPV), and negative predictive value (NPV) were calculated. The Kaplan-Meier method was used to construct survival curves, and the log-rank test was used to compare time to death, with respect to MELD and CTP categories.

Results: Among the assessed scores, the highest area under the ROC curve (AUC) in univariate logistic regression analysis was calculated for ΔMELD ≥ 1, followed by ΔCTP ≥ 1, CTP > 8, and MELD > 17. Based on the selected criteria, multivariate models were created that were characterized by an outstanding ability to predict the in-hospital mortality.

Conclusions: In-hospital mortality is relatively high in patients with liver cirrhosis. The combination of CTP and MELD scoring methods, combined with their kinetics, allows for the prediction of short-term mortality.

Citing Articles

The prognostic nutritional index is an effective prognostic and nutritional status indicator for cirrhosis.

Ao Z, Chen X, Zhu W, Long H, Wang Q, Wu Q BMC Gastroenterol. 2025; 25(1):107.

PMID: 39994834 PMC: 11849323. DOI: 10.1186/s12876-025-03599-3.


Adverse outcomes after non-hepatic surgeries in patients with alcoholic liver diseases: a propensity-score matched study.

Wu H, Chang C, Yeh C, Chen M, Cherng Y, Chen T BMC Gastroenterol. 2022; 22(1):475.

PMID: 36404314 PMC: 9677632. DOI: 10.1186/s12876-022-02558-6.


Elective Transjugular Intrahepatic Portosystemic Shunt Using Viatorr Stent-Grafts: A Single-Center Experience from China.

Li Y, Wan Y, Wu H, Huang S J Belg Soc Radiol. 2022; 106(1):62.

PMID: 35854822 PMC: 9248993. DOI: 10.5334/jbsr.2741.


Plateletcrit for predicting prognosis in patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloid.

Tu H, Li M, Chen Z, Zhao J, Wang H, Qian J J Clin Lab Anal. 2022; 36(2):e24240.

PMID: 35034375 PMC: 8841175. DOI: 10.1002/jcla.24240.


Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study.

Poo J, Torre A, Aguilar-Ramirez J, Cruz M, Mejia-Cuan L, Cerda E Hepatol Int. 2020; 14(5):817-827.

PMID: 32813194 PMC: 7561536. DOI: 10.1007/s12072-020-10069-3.


References
1.
Bambha K, Kim W, Kremers W, Therneau T, Kamath P, Wiesner R . Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant. 2004; 4(11):1798-804. DOI: 10.1111/j.1600-6143.2004.00550.x. View

2.
Sumskiene J, Kupcinskas L, Pundzius J, Sumskas L . Prognostic factors for short and long-term survival in patients selected for liver transplantation. Medicina (Kaunas). 2005; 41(1):39-46. View

3.
Kraja B, Sina M, Mone I, Pupuleku F, Babameto A, Prifti S . Predictive Value of the Model of End-Stage Liver Disease in Cirrhotic Patients with and without Spontaneous Bacterial Peritonitis. Gastroenterol Res Pract. 2012; 2012:539059. PMC: 3296141. DOI: 10.1155/2012/539059. View

4.
Peeraphatdit T, Naksuk N, Thongprayoon C, Harmsen W, Therneau T, Ricci P . Prognostic Value of Model for End-Stage Liver Disease Score Measurements on a Daily Basis in Critically Ill Patients With Cirrhosis. Mayo Clin Proc. 2015; 90(9):1196-206. PMC: 4567441. DOI: 10.1016/j.mayocp.2015.06.017. View

5.
Cheng X, Zhao J, Chen Y, Meng F, Xu B, Yu H . Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis. Eur J Gastroenterol Hepatol. 2015; 28(4):444-8. PMC: 4777221. DOI: 10.1097/MEG.0000000000000538. View